Hualien, Taiwan

Yu-Tsai Yang

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yu-Tsai Yang: Innovator in Oral Drug Delivery Systems

Introduction

Yu-Tsai Yang is a prominent inventor based in Hualien, Taiwan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of drug delivery systems. His innovative approach addresses the challenges associated with the oral administration of unstable or poorly-absorbed drugs.

Latest Patents

Yu-Tsai Yang holds a patent for "Oral administration of unstable or poorly-absorbed drugs." This patent focuses on dosage forms and combinations that facilitate effective oral administration of drugs that are typically unsuitable for this route due to degradation caused by acid and digestive enzymes. The invention includes a self-microemulsifying drug delivery system (SMEDDS) that, when co-administered with an antacid, can prevent drug degradation and enhance absorption in the gastrointestinal tract. This technology has the potential to effectively administer insulin orally, allowing for long-term storage and reconstitution before use.

Career Highlights

Throughout his career, Yu-Tsai Yang has been associated with Innopharmax, Inc., where he has contributed to the development of innovative drug delivery solutions. His work has garnered attention for its practical applications in improving patient outcomes through enhanced drug absorption.

Collaborations

Yu-Tsai Yang has collaborated with notable colleagues, including Jong-Jing Wang and Pei-Jing Hsu, to advance research and development in the pharmaceutical field. Their combined expertise has played a crucial role in the success of various projects.

Conclusion

In summary, Yu-Tsai Yang is a key figure in the innovation of oral drug delivery systems, with a focus on improving the administration of challenging medications. His contributions continue to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…